Patents
Literature
4 results about "Antiangiogenic agents" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Conjugates comprising ocular angiogenesis growth factor aptamers and uses thereof in the detection and treatment of ophthalmological angiogenesis indications
Provided is an antiangiogenic agent in the form of a vehicle, e.g., a nanoparticle associated (directly or indirectly) with at least one ocular angiogenesis growth factor aptamer, wherein said association labile to interaction between the aptamer and an ocular angiogenesis growth factor.
Owner:YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD +1
Anti-angiogenic agent and methods of using such agent
ActiveUS12410230B2Immunoglobulin superfamilyPeptide/protein ingredientsAntiangiogenic agentsPharmaceutical drug
Anti-angiogenic agents or polypeptides have an amino acid segment substantially similar to domain one of CD2. The polypeptide has a β-sheet formed by two segments. Methods of using such agents and polypeptide are also included.
Owner:GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC
Antiangiogenic Agents and Methods of Using Such Agents
The antiangiogenic agent or polypeptide has an amino acid segment substantially similar to domain 1 of CD2. The polypeptide has a β-sheet formed by the two segments. Methods of using such agents and polypeptides are also included. The agent or polypeptide has a terminal glycine.
Owner:GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC
Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
PendingUS20250295869A1RespiratorsDispersed particle filtrationAntiangiogenic agentsHypoxia activated prodrug
Owner:IMMUNOGENESIS INC